DEF 14C

DEFINITIVE SCHEDULE 14C

Company: Pharmagreen Biotech Inc.
Filed: October 28, 2020
Period of Report: October 15, 2020
Accession Number: 0001273511-20-000234

View Document ↗ View on SEC.gov ↗